Search our
Current Studies

Still have some questions about the process? Review our Frequently Asked Questions for the answers.
Learn More
Image

Protocol I8F-MC-GPGL A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients with Type 2 Diabetes (SURPASS-2)

Location(s): Lake CIty

Condition: Diabetes

A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients With Chronic KIdney Disease and Hyperuricaemia

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Kidney Disease

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Diabetes

A Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Study to Evaluate the Safety and Efficacy of Repeated Oral Doses of Blautix in Adult Subjects With Irritable Bowel Syndrome (IBS) Subtypes IBS-C and IBS-D

Location(s): St. Augustine

Condition: Gastrointestinal Disease

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon, St. Augustine

Condition: Cholesterol, Heart Disease

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Location(s): Jacksonville (Headquarters)

Condition: Diabetes

A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown)

Condition: Kidney Disease

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Location(s): Jacksonville (Headquarters)

Condition: Heart Disease, Heart Failure